Eric S Fain sold $8,183 of OBIO
director at Orchestra BioMed Holdings, Inc.. 2,683 shares at an average of $3.05, traded Jun 26, 2025, filed Jun 27, 2025.
Score components
- +15RoleDirector
- 0Trade size$8k at market
- 0Share of holdings soldSold 5.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +18.3%, 3m -13.0%, 6m +55.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-063693, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 26, 2025 | SOpen-market sale Common Stock, par value $0.0001 per share ("Common Stock")indirect: By the Fain Living Trust | -2,683 | $3.05 | $8,183 | 50,949 | Jun 27, 2025 |
Related signals
Other insiders at Orchestra BioMed Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $95k 15,000 shares | -1% | |
| 17Weak | OBIObuy Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $48k 10,000 shares | +1% | |
| 3Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $74k 15,000 shares | -1% | |
| 32Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $19k 5,000 shares | +0% | |
| 2Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $58k 15,000 shares | -1% | |
| 34Weak | Orchestra BioMed Holdings, Inc. | Jason Aryeh director | $2,494 665 shares | +1% | |
| 47Moderate | Orchestra BioMed Holdings, Inc. | Jason Aryeh director | $35k 8,971 shares | +8% | |
| 38Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $19k 5,000 shares | +0% | |
| 49Moderate | Orchestra BioMed Holdings, Inc. | Eric S Fain director | $83k 20,000 shares | +28% | |
| 12Weak | OBIOsell Orchestra BioMed Holdings, Inc. | Rtw Investments, LP owner | $132 32 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.